Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
PaperCitations, authors & open-access status
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 975 citations, 2015 year and closed oa status.
975
Citations
2015
Year
closed
OA Status